Updated on 31 August 2026
Pilot Medical Group (Healthcare and Longevity Program)
CEO and CIO at DF Group
China (Hong Kong)
About
Our platform currently consists of:
Pilot Medical Clinic — a Ministry of Health–licensed medical clinic in Singapore focused on preventive medicine, longevity healthcare, and advanced diagnostics.
Pilot Healthcare — our innovation integration platform that identifies, evaluates, and deploys emerging medical technologies from leading global innovation ecosystems.
Our Mission
Advancing Preventive and Longevity Medicine
Through our clinical platform, we introduce AI-enabled health assessment tools that help identify high-risk individuals and guide targeted screening, together with next-generation medical-grade diagnostics and emerging healthcare technologies.
Together, these capabilities enable earlier detection, more precise diagnosis, and personalized care pathways, supporting the advancement of preventive and longevity-focused healthcare.
Responsible Innovation in Healthcare
Innovation within our ecosystem is introduced with strong emphasis on clinical governance, regulatory awareness, and transparency to patients and users.
Medical services are delivered under physician supervision through our licensed clinical practice. Digital health and AI-enabled tools that are not classified as medical services are deployed with clear disclosures regarding their purpose and limitations, and users participate with informed consent prior to use.
This framework allows emerging healthcare technologies to be responsibly evaluated while maintaining high standards of patient safety, ethical practice, and regulatory compliance.
A Gateway for Global Healthcare Innovation
Pilot Medical Group collaborates with universities, research institutions, and healthcare technology companies across North America, Europe, and Asia to introduce promising medical innovations into structured clinical environments.
For innovators, our platform provides:
-
Access to a regulated clinical setting for real-world validation
-
Structured pilot programs for emerging healthcare technologies
-
Support in navigating regional regulatory and clinical environments
-
A pathway to enter the rapidly growing ASEAN healthcare market
Through these collaborations, we help bridge the gap between research, clinical validation, and commercialization.
At Pilot Medical Group, we believe the future of healthcare lies not only in discovering new technologies, but in bringing the right innovations into clinical practice safely, responsibly, and efficiently.
Project Location
- China (Hong Kong)
Project Website
https://www.pilotmedicalgroup.com/
Project Format
- Private Project
Go Global Project
- Yes
ESG (Environmental, Social, and Governance)
- No
Project Stage
- Investment / Financing Discussion
Main Project Sector
- Technology
Technology
- Medical Technology
Total Project Value
- 2,500,001 to 5,000,000 USD
Investment Capital Required
- 1,000,001 to 2,500,000 USD
Type(s) of Last Financing Round of the project (if Applicable)
- Venture Capital (VC)
Main Service(s) Required
- Financial Services
- Information Technology Services
- Professional Services
Organisation
China (Hong Kong)
Similar opportunities
Service
Regulatory Affairs & Market Access Solutions for Greater China and Asia
- East Asia
- Consultancy
- Mainland China
- South-East Asia
- Professional Services
- Market Entry Strategic Analysis
Jacky Li
Vice President at Cisema
China (Hong Kong)
Project
Cross‑border Digital Medical Marketplace Project — Doctor‑Mall
- Yes
- Yes
- Equity
- E-payment
- Technology
- IP Related
- IT Security
- Consultancy
- Tax Advisory
- Joint Venture
- Bootstrapping
- IT Consulting
- Cloud Solution
- Legal Advisory
- Public Project
- Mobile Solutions
- Health Technology
- Big Data Solution
- Digital Marketing
- Financial Services
- Corporate Services
- Financial Advisory
- Legal Due Diligence
- Open for negotiation
- Open for Negotiation
- Professional Services
- Minority Shareholdings
- Requisition of Service
- Financial Due Diligence
- Direct Equity Investment
- Institutional Investment
- 1,000,001 to 2,500,000 USD
- 1,000,001 to 2,500,000 USD
- Feasibility Study Completed
- Information Technology Services
- Market Entry Strategic Analysis
- Private Equity & Venture Capital
- Risk Management (Financial Services)
Fairy LI
CEO at WELLNEST HEALTHCARE TECHNOLOGY CO., LIMITED
China (Hong Kong)
Project
AI-Enabled Quantitative MRI Platform for Early Disease Assessment
- No
- No
- Equity
- Technology
- Private Project
- Convertible Loan
- Equity (private)
- Financial Services
- Open for Negotiation
- Direct Equity Investment
- 1,000,001 to 2,500,000 USD
- 7,500,001 to 10,000,000 USD
- Investment / Financing Discussion
Carmen Ng
CEO at CAPRiser Group
Canada